Dr. Ning Xu has many years of experience of clinical research in both the pharmaceutical and CRO industries. He currently serves as Vice President, Head of Clinical Development Service, for Covance China. Dr. Xu has worked for such pharmaceutical companies as J&J and GSK, and has also served for such CROs as Excel PharmaStudies and Parexel in the US. Dr. Xu earned his MD from Peking Union Medical College. He worked as a pulmonary physician in Beijing Union Hospital for six years before completing his postdoctoral fellowship at the Medical School, University of Illinois at Chicago, investigating neutrophil inhibitory factor in preventing acute lung injury. He subsequently received his MBA from the University of Illinois at Chicago.